One of these markers is the HER2 antigen (also called HER-2, ERBB2, p185HER-2), which is overexpressed in a wide variety of human neoplasms [23], particularly in ovarian and breast carcinomas [24], [25]. Here, ERBB2 is linked to breast carcinoma.